ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 185 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,828,000 | -55.4% | 227,331 | -73.5% | 0.00% | -50.0% |
| Q2 2016 | $6,338,000 | +6367.3% | 857,630 | +5500.7% | 0.00% | – |
| Q1 2016 | $98,000 | -62.0% | 15,313 | -62.9% | 0.00% | – |
| Q4 2015 | $258,000 | +19.4% | 41,273 | +11.4% | 0.00% | – |
| Q3 2015 | $216,000 | -99.0% | 37,045 | -98.6% | 0.00% | -100.0% |
| Q2 2015 | $21,474,000 | -7.8% | 2,596,646 | -8.2% | 0.01% | -11.1% |
| Q1 2015 | $23,303,000 | +344.5% | 2,828,095 | +270.5% | 0.01% | +350.0% |
| Q4 2014 | $5,243,000 | +8356.5% | 763,221 | +9812.0% | 0.00% | – |
| Q1 2014 | $62,000 | +933.3% | 7,700 | +782.0% | 0.00% | – |
| Q4 2013 | $6,000 | -100.0% | 873 | -100.0% | 0.00% | -100.0% |
| Q3 2013 | $33,183,000 | +29.4% | 1,803,399 | +23.0% | 0.01% | +16.7% |
| Q2 2013 | $25,643,000 | – | 1,466,115 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |